P04.65 Towards new therapies for glioblastoma treatment: role of Dkk-3 and Claudin-5

BACKGROUND: Glioblastomas (GBM) are highly aggressive brain tumors commonly treated with a combination of surgery, radiation therapy, and systemic chemotherapy. However, despite recent improvement in the multimodality approach, patient median survival times range between 3 and 30 months. New data by...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Caffo, M, Esposito, E, Casili, G, Barresi, V, Caruso, G, Lanza, M, Gorgoglione, N, Germanò, A, Cuzzocrea, S, Cardali, S M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Poster Presentations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144314/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.299
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia